Publications en collaboration avec des chercheurs de University Hospital of Bern (38)

2024

  1. Changes in incidence of hepatitis C virus reinfection and access to direct-acting antiviral therapies in people with HIV from six countries, 2010–19: an analysis of data from a consortium of prospective cohort studies

    The Lancet HIV, Vol. 11, Núm. 2, pp. e106-e116

  2. Management of Impulse Control and Related Disorders in Parkinson's Disease: An Expert Consensus

    Movement Disorders, Vol. 39, Núm. 2, pp. 235-248

  3. Non-Invasive Imaging Techniques for Diagnosis of Pelvic Deep Endometriosis and Endometriosis Classification Systems: An International Consensus Statement

    Journal of Minimally Invasive Gynecology, Vol. 31, Núm. 7, pp. 557-573

  4. Safety of pulsed field ablation in more than 17,000 patients with atrial fibrillation in the MANIFEST-17K study

    Nature Medicine, Vol. 30, Núm. 7, pp. 2020-2029

2023

  1. BOHEMIA: Broad One Health Endectocide-based Malaria Intervention in Africa—a phase III cluster-randomized, open-label, clinical trial to study the safety and efficacy of ivermectin mass drug administration to reduce malaria transmission in two African settings

    Trials, Vol. 24, Núm. 1

  2. Genetic reanalysis of patients with a difference of sex development carrying the NR5A1/SF-1 variant p.Gly146Ala has discovered other likely disease-causing variations

    PloS one, Vol. 18, Núm. 7, pp. e0287515

  3. Neuroblastoma RAS viral oncogene homolog (N-RAS) deficiency aggravates liver injury and fibrosis

    Cell death & disease, Vol. 14, Núm. 8, pp. 514

  4. Pharmacokinetics of ivermectin metabolites and their activity against Anopheles stephensi mosquitoes

    Malaria Journal, Vol. 22, Núm. 1

  5. Preoperative airway ultrasound assessment in the sniffing position: a prospective observational study

    Brazilian Journal of Anesthesiology (English Edition), Vol. 73, Núm. 5, pp. 539-547

2022

  1. Antibody Response in Immunocompromised Patients After the Administration of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Vaccine BNT162b2 or mRNA-1273: A Randomized Controlled Trial

    Clinical Infectious Diseases, Vol. 75, Núm. 1, pp. E585-E593

  2. Consensus Statement on Bone Conduction Devices and Active Middle Ear Implants in Conductive and Mixed Hearing Loss

    Otology and Neurotology, Vol. 43, Núm. 5, pp. 513-529

  3. Data on the effect of early treatment with ivermectin on viral load, symptoms and humoral response in patients with mild COVID-19.

    CORA.Repositori de Dades de Recerca

  4. Early short course of neuromuscular blocking agents in patients with COVID-19 ARDS: a propensity score analysis

    Critical Care, Vol. 26, Núm. 1

  5. Effectiveness of Antiviral Therapy in Highly-Transmissible Variants of SARS-CoV-2: A Modeling and Simulation Study

    Frontiers in Pharmacology, Vol. 13

  6. Next generation in ultrasound imaging to assess upper airway

    Brazilian Journal of Anesthesiology (English Edition), Vol. 72, Núm. 5, pp. 673-675

  7. The European Registry for Patients with Mechanical Circulatory Support of the European Association for Cardio-Thoracic Surgery: third report

    European Journal of Cardio-thoracic Surgery, Vol. 62, Núm. 1

2021

  1. Assessing the impact of COVID-19 on liver cancer management (CERO-19)

    JHEP Reports, Vol. 3, Núm. 3

  2. Elective Cancer Surgery in COVID-19-Free Surgical Pathways during the SARS-CoV-2 Pandemic: An International, Multicenter, Comparative Cohort Study

    Journal of Clinical Oncology, Vol. 39, Núm. 1, pp. 66-78

  3. Modeling of SARS-CoV-2 Treatment Effects for Informed Drug Repurposing

    Frontiers in Pharmacology, Vol. 12

  4. Potential metabolic resistance mechanisms to ivermectin in Anopheles gambiae: a synergist bioassay study

    Parasites and Vectors, Vol. 14, Núm. 1